University of Pittsburgh researchers have developed an innovative 3D bioprinting platform capable of generating functional primary and induced pluripotent stem cell (iPSC)-derived organoids within hydrogel constructs. This innovative technology leverages a unique bioink formulation and 3D printing protocol to create stable, high-resolution 3D tissue structures that can be used for various biomedical applications, including drug discovery, disease modeling, transplantation, and personalized cellular therapy.
